Advance Search
SONG Jin. Clinical effect of butylphthalide injection combined with rosuvastatin calcium tablets in the treatment of acute progressive cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 45-47, 51. DOI: 10.7619/jcmp.201917013
Citation: SONG Jin. Clinical effect of butylphthalide injection combined with rosuvastatin calcium tablets in the treatment of acute progressive cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 45-47, 51. DOI: 10.7619/jcmp.201917013
shu

Clinical effect of butylphthalide injection combined with rosuvastatin calcium tablets in the treatment of acute progressive cerebral infarction

  • Baoji Second People′s Hospital, Baoji, Shaanxi, 721000

More Information
  • Received Date: June 28, 2019
  • Accepted Date: August 25, 2019
  • Available Online: February 28, 2021
  • Published Date: September 14, 2019
    Graphical Abstract
    • Abstract
  •   Objective  To evaluate the efficacy of butylphthalide injection combined with rosuvastatin calcium tablets for patients with acute progressive cerebral infarction and its impact on high sensitivity C reactive protein (hs-CRP) and neurological function.
      Methods  A total of 120 patients with acute progressive cerebral infarction were divided into two groups according to random number table method. The control group was given rosuvastatin calcium tablets, while the study group received butylphthalide injection and rosuvastatin calcium tablets. Clinical effects, hs-CRP level, National Institutes of Health Stroke Scale(NIHSS)score, modified mental state scale(MMSR)score, homocysteine(Hcy), tumor necrosis factor-α(TNF-α), low density lipoprotein cholesterol(LDL-C).
      Results  After treatment, the total effective rate of the study group was higher than that of the control group(P < 0.05). The NIHSS score of the study group was lower, and MMSR score was higher than that of the control group, and Hcy, hs-CRP, TNF-α and LDL-C levels in the study group were lower than that of the control group(P < 0.05).
      Conclusion  Butylphthalide injection combined with rosuvastatin for patients with acute progressive cerebral infarction can improve clinical outcomes, improve neurological and cognitive function, reduce Hcy, hs-CRP, TNF-α and LDL-C levels.
    • FullText(HTML)
    • References (18)
  • [1]
    李娟, 赵芳芳, 宁方波, 等. 急性进展性缺血性脑卒中血管内治疗的疗效分析[J]. 中华临床医师杂志: 电子版, 2017, 11(3): 375-378. doi: 10.3877/cma.j.issn.1674-0785.2017.03.004
    [2]
    顾玉宝, 刘敬霞, 王枫, 等. 中医药治疗脑梗死的临床研究进展[J]. 中华中医药学刊, 2017, 35(2): 303-306. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201702012.htm
    [3]
    张江, 韩雪, 宋方方. 丁苯酞注射液对不同OCSP分型的急性脑梗死患者的疗效观察[J]. 中华老年心脑血管病杂志, 2018, 20(11): 1174-1178. doi: 10.3969/j.issn.1009-0126.2018.11.013
    [4]
    Noma K, Higashi Y. Cilostazol for treatment of cerebral infarction[J]. Expert Opin Pharmacother, 2018, 19(15): 1719-1726. doi: 10.1080/14656566.2018.1515199
    [5]
    刘欣, 李小刚, 王红霞, 等. 老年轻型缺血性脑卒中早期进展的临床研究[J]. 中华老年心脑血管病杂志, 2018, 20(4): 401-404. doi: 10.3969/j.issn.1009-0126.2018.04.017
    [6]
    Abdulla M C, Saseendran R. Transient left alien hand syndrome after left anterior cerebral artery infarction[J]. Ann Indian Acad Neurol, 2019, 22(1): 118-119. doi: 10.4103/aian.AIAN_143_18
    [7]
    张文昭, 乔雪竹, 李家琪, 等. 皮质下型分水岭脑梗死发病机制与临床特点研究进展[J]. 中华老年心脑血管病杂志, 2018, 20(1): 105-107. doi: 10.3969/j.issn.1009-0126.2018.01.028
    [8]
    Song M K, Kim E J, Kim J K, et al. Effect of regular swimming exercise to duration-intensity on neurocognitive function in cerebral infarction rat model[J]. Neurol Res, 2019, 41(1): 37-44. doi: 10.1080/01616412.2018.1524087
    [9]
    张力文, 万云高, 马欣, 等. 伴糖尿病的心肌梗死及脑梗死对比研究进展[J]. 中华老年心脑血管病杂志, 2017, 19(8): 893-896. doi: 10.3969/j.issn.1009-0126.2017.08.028
    [10]
    宋晓明, 郑珍婕, 苏立静, 等. 丁苯酞序贯治疗对急性进展性脑梗死患者神经功能、炎症因子及Hcy、NSE的影响[J]. 中华全科医学, 2017, 15(3): 434-436. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201703022.htm
    [11]
    刘运涌, 王全保, 李伟, 等. CD4 CD25免疫调节性T细胞和颈动脉斑块性质与老年进展性脑梗死的相关分析[J]. 中华老年心脑血管病杂志, 2017, 19(7): 735-737. doi: 10.3969/j.issn.1009-0126.2017.07.015
    [12]
    张岩, 张丽, 徐如祥. 依达拉奉给药途径及治疗急性脑梗死的研究进展[J]. 中华神经创伤外科电子杂志, 2017, 3(1): 44-47. doi: 10.3877/cma.j.issn.2095-9141.2017.01.011
    [13]
    张敏, 于莉, 郑美玲, 等. 丁苯酞注射液联合瑞舒伐他汀钙片治疗急性进展性脑梗死的临床研究[J]. 中国临床药理学杂志, 2019, 35(3): 203-205. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201903003.htm
    [14]
    胡美铃, 李伟英, 王志敏. 丁苯酞联合瑞舒伐他汀治疗动脉粥样硬化型脑梗死的疗效观察[J]. 浙江实用医学, 2018, 23(4): 242-244, 263. doi: 10.3969/j.issn.1007-3299.2018.04.003
    [15]
    唐艳艳, 李飞泽, 邵海斌, 等. 芪参归汤联合丁苯酞注射液治疗脑梗死的临床观察[J]. 中华中医药学刊, 2017, 35(6): 1570-1572. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201706060.htm
    [16]
    张瑞莲, 任萍, 王俐滢, 等. 瑞舒伐他汀联合依折麦布对老年脑梗死患者C反应蛋白及可溶性细胞黏附分子-1影响研究[J]. 中华保健医学杂志, 2018, 20(2): 135-137. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJB201802048.htm
    [17]
    刘维婕, 刘丹, 刘坤, 等. 复方丹参注射液联合丁苯酞注射液治疗老年急性脑梗死的临床分析[J]. 中华中医药学刊, 2019, 37(5): 1274-1277. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201905064.htm
    [18]
    戴毅, 吴玉泉, 胡金华. 瑞舒伐他汀钙对急性脑梗死患者血脂和血清超敏C反应蛋白的影响[J]. 中华全科医学, 2015, 13(6): 924-925, 1036. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201506022.htm
    • Related Articles

  • Related Articles

    [1]WANG Ping, LIU Jianrong, YU Lei, MA Lifen, ZHAO Lili. Correlations of serum stromal cell-derived factor-1, chemokine receptor 7 and vascular density in the optic disc area with clinical stages in patients with normal-tension glaucoma[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 1-5. DOI: 10.7619/jcmp.20244420
    [2]GU Jianguo, NI Jie, SI Guojun. Correlation of serum B-cell activating factor level with cardiovascular events in patients with ST segment elevation myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 52-56. DOI: 10.7619/jcmp.20233732
    [3]QIN Lei, QIN Xin. Myeloid differentiation factor 88 regulates the proliferation, migration and invasion of colorectal cancer cells through the nuclear factor-κB/activator protein-1 signaling pathway[J]. Journal of Clinical Medicine in Practice, 2023, 27(14): 40-45. DOI: 10.7619/jcmp.20223737
    [4]GU Fengjuan, XU Zibin, XU Yunpeng, ZHANG Yanzi, LI Lixiang, SUI Xiaolu, ZOU Jiefeng, ZENG Qicheng, XIE Tingfei, CHEN Jihong. Mechanism of Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway in model micewith focal segmental glomerulosclerosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 74-79. DOI: 10.7619/jcmp.20222730
    [5]YUAN Hongli, WANG Xian, WANG Xiumei, ZHOU Yu. Clinical significance of angiogenin protein 4, interleukin-17 and nuclear factor-kappa B ligand in serum and articular fluid of patients with rheumatoid arthritis[J]. Journal of Clinical Medicine in Practice, 2022, 26(17): 57-62. DOI: 10.7619/jcmp.20220103
    [6]LIAO Dongsheng, A Huaihong, LI Shaohua, GAO Chunyuan, SHEN Jun, WANG Hongjun. Changes of serum adropin, platelet activating factor and glial fibrillary acidic protein levels in patients with coronary heart disease complicating depression and their significance[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 74-77, 82. DOI: 10.7619/jcmp.20212667
    [7]YU Dongqing, CHE Lu. Analysis of the relationships between CD62p, CD63 as well as platelet activating factor expression and clinical prognosis in patients with acute ischemic cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(19): 36-38. DOI: 10.7619/jcmp.20212694
    [8]WANG Qi, ZHOU Xiangdong, HAN Zhong, LIU Chang. Effects of expression of activator protein-1 and polytumour activator in tissue of non-small cell lung cancer on prognosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 1-5. DOI: 10.7619/jcmp.20201847
    [9]LIU Benhong, ZHOU Ning, SUN Mingxiang, YU Jia, GAO Songfeng. The effect of inhaled glucocorticoid therapy on levels of cytokines in serum and sputum of patients with acute exacerbation of the chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2016, (11): 32-34,46. DOI: 10.7619/jcmp.201611010
    [10]LUO Bei-hai. Influence of clopidogrel on the levels of plasma inflammatory factor and platelet activating factor in patients with unstable angina[J]. Journal of Clinical Medicine in Practice, 2012, (7): 75-77. DOI: 10.3969/j.issn.1672-2353.2012.07.024

  • Cited by

    Periodical cited type(11)

    1. 牛绍迁，杨魏东，冯灵，张晓瑶，周琼蓉. 老年卒中后睡眠障碍的影响因素及药物与非药物治疗研究进展. 保健医学研究与实践. 2024(03): 134-138 .
    2. 史哲宇，黄慧丽，朱少炳，朱路文. 近5年血府逐瘀汤在神经系统疾病中的应用及作用机制研究进展. 中医药学报. 2024(11): 109-114 .
    3. 张雯，江丽杰，赵海河. 《医林改错》中活血化瘀类方剂治疗中风的研究进展. 中国中医基础医学杂志. 2023(06): 1036-1039 .
    4. 高娟，张则甫. 血府逐瘀汤联合康复训练对脑卒中后偏瘫足下垂患者下肢肌张力恢复及体感诱发电位的影响. 中国民族医药杂志. 2023(11): 8-10 .
    5. 孙晓. 血府逐瘀胶囊辅治脑卒中后抑郁临床观察. 实用中医药杂志. 2023(12): 2418-2420 .
    6. 乔煦，吴广，王钰. 养心方对缺血性脑卒中后睡眠障碍患者睡眠质量及血清5-HT、BDNF水平的影响. 中医药信息. 2022(02): 60-63 .
    7. 路琦，张永全. 中西医治疗脑卒中后失眠的研究进展. 大众科技. 2022(02): 106-109+113 .
    8. 贾军. 清肺化痰逐瘀汤治疗冠心病临床观察. 光明中医. 2022(08): 1423-1425 .
    9. 沈晓桦，卢根娣，蒋国静，胡丽，谈晓红. 引阳入阴推拿对剖宫产后心脾两虚证产妇睡眠障碍及负性情绪的影响. 实用临床医药杂志. 2022(09): 54-58 . 本站查看
    10. 陈素银. 血府逐瘀汤对缺血性脑卒中患者血清细胞因子水平和脑血流的影响. 光明中医. 2022(13): 2357-2359 .
    11. 徐梦圆，孙平，杨言府. 血府逐瘀汤联合小剂量奥氮平治疗脑卒中后睡眠障碍30例临床观察. 中国民族民间医药. 2022(23): 113-115+118 .

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML
    Article views (289) PDF downloads (4) Cited by(14)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return